cliniq
QBank
Features
Disciplines
Medications
Free questions
Objectives
Pricing
Sign in
Get started
Back to medications
Medication monograph
pegvisomant
Growth Hormone Receptor Antagonists
Pegylated Proteins
Metabolic & Endocrine Agents
Growth Hormone Receptor Antagonist
Somatotropin Antagonists
Clinical reference
Product monograph
SOMAVERT- pegvisomant kit
1 Indications And Usage
2 Dosage And Administration
3 Dosage Forms And Strengths
4 Contraindications
5 Warnings And Precautions
6 Adverse Reactions
7 Drug Interactions
8 Use In Specific Populations
10 Overdosage
11 Description
12 Clinical Pharmacology
13 Nonclinical Toxicology
14 Clinical Studies
16 How Supplied/Storage And Handling
17 Patient Counseling Information
Patient Package Insert
Instructions For Use
Principal Display Panel - 1 Ml Syringe Label
Principal Display Panel - 10 Mg Vial Label
Principal Display Panel - Kit Carton - 7166-01
Principal Display Panel - 10 Mg Vial Carton
Principal Display Panel - Kit Carton - 7166-30
Principal Display Panel - 15 Mg Vial Label
Principal Display Panel - Kit Carton - 7168-01
Principal Display Panel - 15 Mg Vial Carton
Principal Display Panel - Kit Carton - 7168-30
Principal Display Panel - 20 Mg Vial Label
Principal Display Panel - Kit Carton - 7188-01
Principal Display Panel - 20 Mg Vial Carton
Principal Display Panel - Kit Carton - 7188-30
Principal Display Panel - 25 Mg Vial Label
Principal Display Panel - Kit Carton - 7199-01
Principal Display Panel - 25 Mg Vial Carton
Principal Display Panel - Kit Carton - 7199-30
Principal Display Panel - 30 Mg Vial Label
Principal Display Panel - Kit Carton - 7200-01
Principal Display Panel - 30 Mg Vial Carton
Principal Display Panel - Kit Carton - 7200-30
Brands & formulations
Family members
SOMAVERT
Marketed
10 MG
SUBCUTANEOUS
POWDER FOR SOLUTION, KIT
[ "pegvisomant" ]
Product monograph
SOMAVERT
Marketed
15 MG
SUBCUTANEOUS
POWDER FOR SOLUTION, KIT
[ "pegvisomant" ]
Product monograph
SOMAVERT
Marketed
20 MG
SUBCUTANEOUS
KIT, POWDER FOR SOLUTION
[ "pegvisomant" ]
Product monograph
SOMAVERT
Marketed
25 MG
SUBCUTANEOUS
POWDER FOR SOLUTION, KIT
[ "pegvisomant" ]
Product monograph
SOMAVERT
Marketed
30 MG
SUBCUTANEOUS
KIT, POWDER FOR SOLUTION
[ "pegvisomant" ]
Product monograph
Classification
Chemical class
Growth Hormone Receptor Antagonists, Pegylated Proteins
Clinical class
Metabolic & Endocrine Agents
Banks class
Growth Hormone Receptor Antagonist
AHFS family
Somatotropin Antagonists